Protagonist Therapeutics
PTGX
Protagonist Therapeutics Price Chart (PTGX)
| 1h | 24h | 7d | 14d | 30d | 1y |
|---|---|---|---|---|---|
| 1.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
PTGX Converter
Protagonist Therapeutics Historical Prices
| 24h Range | $142.54 – $145.89 |
|---|---|
| 7d Range | $142.54 – $145.89 |
| 52w Range | $142.54 – $145.89 |
Stock Statistics
| Market Cap | - |
|---|
Tokenized Statistics
| Price | - |
|---|---|
| Market Cap | - |
| 24 Hour Trading Vol | - |
| Perps 24h Volume | - |
| Perps 24h Open Interest | - |
| Perps 8h Funding Rate | - |
| Issuers | |
| Contract |
|
| Explorers |
|
| Symbol | PTGXON |
Info
| Website |
protagonist-inc.com
|
|---|---|
| Sector |
Health Care
|
| Industry |
Biotechnology
|
| Asset Type | Stock |
| Country | 🇺🇸 United States |
Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. The company is headquartered in Newark California, California and currently employs 108 full-time employees. The company went IPO on 2016-08-11. The firm's programs fall into three therapeutic areas: inflammation and immunology (I&I), hematology, and metabolic diseases. Its clinical and pre-clinical programs address biologically and commercially validated targets, including IL-17 oral peptide antagonist PN-881, obesity triple agonist peptide PN-477, obesity dual agonist peptide PN-458, oral small molecule hepcidin functional mimetic PN-8047, and IL-4 and amylin programs. The ICOTYDE (icotrokinra) is used for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients 12 years of age or older who weigh at least 40 kg and are candidates for systemic therapy or phototherapy. Rusfertide is an investigational injectable mimetic of the natural hormone hepcidin in development for the treatment of the rare blood disorder polycythemia vera (PV).
How is Protagonist Therapeutics (PTGX) performing?
Protagonist Therapeutics (PTGX) is up 0.0% today, trading at $144.86 with a daily range of $142.54 to $145.89. Over the past year, Protagonist Therapeutics hit a 52-week high of $145.89 and a low of $142.54, and is up 0.0% year-to-date.
What is the market cap of Protagonist Therapeutics (PTGX)?
Protagonist Therapeutics (PTGX) has a market cap of -. To see how PTGX compares to other stocks, check out CoinGecko's list of stocks ranked by market cap.
Who are the different issuers of tokenized Protagonist Therapeutics (PTGX)?
Ondo Finance is the only issuer of tokenized Protagonist Therapeutics on CoinGecko. Their token, PTGXON, has a market cap of -.
Where can I buy tokenized Protagonist Therapeutics (PTGX)?
Tokenized Protagonist Therapeutics (PTGX) is currently not available to trade on any exchanges listed on CoinGecko. Check back later — information will be updated when trading activity resumes.
Protagonist Therapeutics Markets
Protagonist Therapeutics Tokens
| # | Token | Chain | Issuer | Price | Price Diff % | Market Cap | 24h Volume | Perps 24h Volume | Perps 24h OI | |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
PTGXON
|
Ethereum
|
Ondo Finance
|
- | - | - | - | - | - | |
Ondo Finance